Astellas Pharma: Difference between revisions

(One intermediate revision by the same user not shown)

Line 9:

| predecessors = Yamanouchi Pharmaceutical Fujisawa Pharmaceutical (Merged in 2005)

| location = 2-5-1, Nihonbashi-Honcho, [[:en:Chūō, Tokyo|Chūō-ku]], [[:en:Tokyo|Tokyo]] 103-8411, {{Country|Japan}}

| key_people = Naoki Okamura ([[President (corporate title)|President]] and [[:en:CEO|CEO]]) Kenji Yasukawa ([[:en:Chairman of the Board|Chairman of the Board]])

| key_people = Naoki Okamura ([[:en:President (corporate title)|President]] and [[:en:CEO|CEO]]) Kenji Yasukawa ([[:en:Chairman of the Board|Chairman of the Board]])

| industry = [[:en:Pharmaceutical company|Pharmaceutical]]

| products = {{Unbulleted list|[[Prograf/ja|プログラフ]]|[[Harnal/ja|ハルナール]]|[[Vesicare/ja|ベシケア]]|[[Micafungin/ja|ファンガード/マイカミン]]|[[Protopic/ja|プロトピック]]|[[Xtandi/ja|イクスタンジ]]|その他医薬品}}

Line 123:

==Operations==

~~The company's headquarters are in~~ [[~~Tokyo~~]]~~, with~~ [[~~research~~]] ~~centers in~~ [[~~Tsukuba~~]] ~~and~~ [[~~Osaka~~]]~~. Clinical development is centered in~~ [[Northbrook, Illinois]], [[La Jolla, California]]~~, and~~ [[Leiden]], ~~Netherlands. Combined revenues of the two pre-merger companies were $7.9 billion in 2004. Worldwide the company employs about 17,000 people. The United States subsidiary of Astellas is~~ '''Astellas US LLC'''.

~~The company's~~ [[advertising slogan]]~~s are:~~

同社の[[:en:advertising slogan|広告スローガン]]は以下の通りである：

* ~~English:~~ '''Leading Light for Life'''

* 英語：'''Leading Light for Life'''

* ~~Japanese:~~ {{nihongo|'''Ashita wa kaerareru.'''|明日は変えられる。|Changing Tomorrow.}}

* 日本語：{{nihongo|'''Ashita wa kaerareru.'''|明日は変えられる。|Changing Tomorrow.}}

== See also ==

@@ Line 9: / Line 9: @@
 | predecessors  = Yamanouchi Pharmaceutical<br />Fujisawa Pharmaceutical<br />(Merged in 2005)
 | location      = 2-5-1, Nihonbashi-Honcho, [[:en:Chūō, Tokyo|Chūō-ku]], [[:en:Tokyo|Tokyo]] 103-8411, {{Country|Japan}}
-| key_people    = Naoki Okamura<br /><small>([[President (corporate title)|President]] and [[:en:CEO|CEO]])</small><br />Kenji Yasukawa<br /><small>([[:en:Chairman of the Board|Chairman of the Board]])</small>
+| key_people    = Naoki Okamura<br /><small>([[:en:President (corporate title)|President]] and [[:en:CEO|CEO]])</small><br />Kenji Yasukawa<br /><small>([[:en:Chairman of the Board|Chairman of the Board]])</small>
 | industry      = [[:en:Pharmaceutical company|Pharmaceutical]]
 | products      = {{Unbulleted list|[[Prograf/ja|プログラフ]]|[[Harnal/ja|ハルナール]]|[[Vesicare/ja|ベシケア]]|[[Micafungin/ja|ファンガード/マイカミン]]|[[Protopic/ja|プロトピック]]|[[Xtandi/ja|イクスタンジ]]|その他医薬品}}
@@ Line 123: / Line 123: @@
 ==Operations==
-The company's headquarters are in [[Tokyo]], with [[research]] centers in [[Tsukuba]] and [[Osaka]]. Clinical development is centered in [[Northbrook, Illinois]], [[La Jolla, California]], and [[Leiden]], Netherlands. Combined revenues of the two pre-merger companies were $7.9 billion in 2004. Worldwide the company employs about 17,000 people. The United States subsidiary of Astellas is '''Astellas US LLC'''.
+本社は[[:ja:東京|東京]]にあり、[[:ja:筑波市|つくば]]と[[:ja:大阪|大阪]]に[[:ja:研究|研究]]センターがある。臨床開発は[[:en:Northbrook, Illinois|イリノイ州ノースブルック]]、[[:en:La Jolla, California|カリフォルニア州ラホヤ]]、オランダの[[:en:Leiden|ライデン]]を中心に行われている。合併前の2社を合わせた2004年の売上高は79億ドルであった。全世界の従業員数は約17,000人である。アステラスの米国子会社は'''Astellas US LLC'''である。
-The company's [[advertising slogan]]s are:
+同社の[[:en:advertising slogan|広告スローガン]]は以下の通りである：
-* English: '''Leading Light for Life'''
+* 英語：'''Leading Light for Life'''
-* Japanese: {{nihongo|'''Ashita wa kaerareru.'''|明日は変えられる。|Changing Tomorrow.}}
+* 日本語：{{nihongo|'''Ashita wa kaerareru.'''|明日は変えられる。|Changing Tomorrow.}}
 == See also ==